A lumbrokinase isozyme targets hepatitis B e-antigen
This work was supported by the National Natural Science Foundation of China (31470036). The funding bodies had no role in designing the study, or in data collection and analysis, the decision to publish, or in the preparation of this manuscript.
- Jung, M.C., Diepolder, H.M., Spengler, U., Wierenga, E.A., Zachoval, R., Hoffmann, R.M., Eichenlaub, D., Frosner, G., Will, H., and Pape, G.R. (1995). Activation of a heterogeneous hepatitis-B (Hb) core and eantigen-specific CD4(+) T-Cell population during seroconversion to anti-Hbe and anti-Hbs in hepatitis-B virus-infection. J Virol 69, 3358–3368.Google Scholar
- Li, S.Z. (1999). Earthworm in Compendium of Materia Medica, Edited by Wang, Y.J. (People′s Medical Publishing House, Beijing), pp.2100–2104.Google Scholar
- Mo, W.C., Zhao, J., Liu, Y., and He, R.Q. (2018). Nanozyme also acts in enzyme-like denaturation? Prog Biochem Biophys 45, 268–271.Google Scholar
- Wang, X.M., Fan, S.C., Chen, Y., Ma, X.F., and He, R.Q. (2018). Earthworm protease in anti-thrombosis and anti-fibrosis. Biochem Biophys Acta-GS https://doi.org/10.1016/j.bbagen.2018.11.006.Google Scholar